Becton, Dickinson and Company Q4: Shifting To High-Growth Areas [Seeking Alpha]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Seeking Alpha
Follow Play 5min Summary Becton, Dickinson and Company is projected to achieve 8.8%-9.3% revenue growth in FY25, driven by new product launches and the APM business. The acquisition of Edwards Lifesciences' Critical Care product group is expected to significantly boost BD's Advanced Patient Monitoring segment. BD plans to reduce debt leverage to 2.5x and repurchase $1 billion in shares, enhancing financial stability and shareholder value. Despite potential headwinds from China, BD's shift towards high-growth areas and steady margin expansion supports a “Buy” rating with a $270 fair value. Arctic-Images In my previous “Buy” rating in September 2024, I discussed Becton, Dickinson and Company's NYSE: BDX ) growth potential in the GLP-1 drug delivery market. The company delivered 4.2% constant revenue growth in FY24, and is guiding for 8.8%-9.3% revenue growth This article was written by Lighting Rock Research 1.65K Follower s Follow I am a growth-oriented inv
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- Flow Cytometry Market Expected To Reach USD 11553.44 Mn by 2032, Growing at 8.21% CAGR | Introspective Market Research [Yahoo! Finance]Yahoo! Finance
- First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities [Yahoo! Finance]Yahoo! Finance
- First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved CommunitiesPR Newswire
- BD to Present at the 7th Annual Evercore ISI HealthCONx ConferencePR Newswire
- Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]Yahoo! Finance
BDX
Earnings
- 11/7/24 - Beat
BDX
Sec Filings
- 11/7/24 - Form 8-K
- 11/5/24 - Form 4
- 11/5/24 - Form 4
- BDX's page on the SEC website